Research Papers:
A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 3423 views | HTML 3455 views | ?
Abstract
Xin Zhou1,*, Wei Wen2,*, Jun Zhu3,*, Zebo Huang1, Lan Zhang1, Huo Zhang1, Lian-Wen Qi4, Xia Shan5, Tongshan Wang1, Wenfang Cheng6, Danxia Zhu7, Yin Yin8, Yan Chen9, Wei Zhu1, Yongqian Shu1,10, Ping Liu1,10
1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China
2Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China
3Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing 210009, PR China
4State Key Laboratory of Natural Medicines and Department of Pharmacognosy, China Pharmaceutical University, Nanjing 210009, PR China
5Department of Respiration, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 210000, PR China
6Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China
7Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, PR China
8Department of Obstetrics and Gynecology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China
9Department of Emergency, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China
10Cancer Center of Nanjing Medical University, Nanjing 210029, PR China
*These authors contributed equally to this work
Correspondence to:
Wei Zhu, email: [email protected]
Ping Liu, email: [email protected]
Keywords: miRNA, esophageal squamous cell carcinoma, diagnosis, exosomes, TCGA
Received: October 25, 2016 Accepted: March 15, 2017 Published: March 23, 2017
ABSTRACT
The differential expression of microRNAs (miRNAs) in plasma of esophageal squamous cell carcinoma (ESCC) patients may serve as a diagnostic biomarker. A four-stage study was conducted to identify plasma miRNAs with potential in detecting ESCC. Exiqon panels (2 ESCC pools vs. 1 normal control (NC) pool) were applied in the screening phase to obtain miRNA profiles. The identified miRNAs were further evaluated through training (36 ESCC VS. 42 NCs) and testing stages (101 ESCC VS. 113 NCs) with qRT-PCR assays. A six-miRNA signature including up-regulated miR-106a, miR-18a, miR-20b, miR-486-5p, miR-584 and down-regulated miR-223-3p in ESCC was identified. The signature could accurately discriminate ESCC patients from NCs with areas under the receiver operating characteristic curve of 0.935, 0.959 and 0.966 for the training, testing and the additional validation stage (41 ESCC VS. 50 NCs), respectively. MiR-106a and miR-584 were significantly up-regulated in tumor tissues with qRT-PCR assays. And miR-584 was also up-regulated in ESCC tissues from TCGA database. In addition, exosomal miR-223-3p and miR-584 were consistently dysregulated with those in plasma and could also act as biomarkers in diagnosis of ESCC. In conclusion, we identified a six-miRNA signature in plasma which could act as a non-invasive biomarker in detection of ESCC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16519